U.S. prices for the world's 20 top-selling medicines are, on average, three times higher than in Britain, according to an analysis carried out for Reuters.
The finding underscores a transatlantic gulf between the price of treatments for a range of diseases and follows demands for lower drug costs in America from industry critics such as Democratic presidential candidate Hillary Clinton.
The 20 medicines, which together accounted for 15 percent of global pharmaceuticals spending in 2014, are a major source of profits for companies including AbbVie (ABBV.N), AstraZeneca (AZN.L), Merck (MRK.N), Pfizer (PFE.N) and Roche (ROG.VX).
(Score: 2) by PartTimeZombie on Friday October 16 2015, @01:27AM
fwiw, I was out of work for over 9 months (I may have a lead on a job now, finally!) - and I ended up in calif's 'poor people health insurance'
What civilised countries do here is pay for health care for everyone from general taxation.
What that meant for me is that when I was diagnosed with diverticulitis at the age of about 40 I had to wait something like 6 weeks for a surgical appointment to get a bowel resection (which cured the problem completely).
This cost me nothing at all (up front, I had been paying tax for 23 years at the time) and was done in a public hospital.
If health care is paid for out of the general fund, rather than some sort of special fund like "national insurance" or whatever, it's a lot harder for politicians to mess with the funding, as the UK is finding out right now.
Oh, New Zealand by the way.